As a contract development and manufacturing organisation (CDMO), we offer a range of custom chemical synthesis, medicinal chemistry libraries, reference standards, API development and manufacturing services from our facility in Cary, North Carolina and our facilities across the globe.
At our Cary site, our world-class facilities support your product from pre-clinical through to Phase ll, volumes from millilitres up to 200-litre batches, ideal for small volume commercial products or products in the early stages of clinical trials.
Our facility features cGMP API manufacturing capabilities and allows us to produce high value, low volume small molecules including high barrier to entry compounds that are generally difficult to manufacture.
Click here to discover more about our Cary facility.
Sterling's Cary facility
Opened in 1994
27,000sq/ft from 14,000sq/ft
50 employees; 17 PhDs, 7 MS
Approved for schedule 1 to 5 controlled substances
40+ molecules
Three GMP synthesis laboratories
Three R&D laboratories
cGMP analytical laboratory
Related Content
PDMO
North Carolina, US
Top 10 early phase considerations
Molecule Lifecycle
Spotlight
